UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Establishment of Reference Reagents for Single-Radial-Immunodiffusion Assay on the 2022/23 Seasonal Influenza Vaccine in Japan and Their Quality Validation

Japanese Journal of Infectious Diseases, 2024/03/29, Vol.77(2), pp.105-111

2024

Link zum Volltext

Verfügbarkeit prüfen

Deciphering antigen-responding antibody repertoires by using next-generation sequencing and confirming them through antibody-gene synthesis

Biochemical and biophysical research communications, 2017-05, Vol.487 (2), p.300-306

2017

Link zum Volltext

Verfügbarkeit prüfen

Distorted antibody repertoire developed in the absence of pre-B cell receptor formation

Biochemical and biophysical research communications, 2018-01, Vol.495 (1), p.1411-1417

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine

Heliyon, 2019-01, Vol.5 (1), p.e01113-e01113, Article e01113

2019

Link zum Volltext

Verfügbarkeit prüfen

Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin

Biochemical and biophysical research communications, 2012-02, Vol.418 (1), p.38-43

2012

Link zum Volltext

Verfügbarkeit prüfen

Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide

Bioorganic & medicinal chemistry, 2010-07, Vol.18 (14), p.5379-5390

2010

Link zum Volltext

Verfügbarkeit prüfen

Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin

PloS one, 2014-06, Vol.9 (6), p.e99201-e99201

2014

Link zum Volltext

Verfügbarkeit prüfen

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice

International immunology, 2004-10, Vol.16 (10), p.1423-1430

2004

Link zum Volltext

Verfügbarkeit prüfen

Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection

Microbes and infection, 2006-10, Vol.8 (12), p.2706-2714

2006

Link zum Volltext

Verfügbarkeit prüfen

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate

Vaccine, 2006-04, Vol.24 (17), p.3669-3676

2006

Link zum Volltext

Verfügbarkeit prüfen

Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer

Journal of epidemiology, 2008, Vol.18 (4), p.160-166

2008

Link zum Volltext

Verfügbarkeit prüfen

Newly Established Monoclonal Antibodies for Immunological Detection of H5N1 Influenza Virus

Japanese Journal of Infectious Diseases, 2012/01/31, Vol.65(1), pp.19-27

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection

Microbiology and immunology, 2010-02, Vol.54 (2), p.81-88

2010

Link zum Volltext

Verfügbarkeit prüfen

Avirulent Avian Influenza Virus as a Vaccine Strain against a Potential Human Pandemic

Journal of Virology, 1999-10, Vol.73 (10), p.8303-8307

1999

Link zum Volltext

Verfügbarkeit prüfen

Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan

Vaccine, 2019-10, Vol.37 (43), p.6573-6579

2019

Link zum Volltext

Verfügbarkeit prüfen

Establishment of reference reagents for single-radial-immunodiffusion assay on the 2022/23 seasonal influenza vaccine in Japan and their quality validation

Japanese Journal of Infectious Diseases, 2023/11/30, pp.JJID.2023.218

2023

Link zum Volltext

Verfügbarkeit prüfen

Evolution of H5N1 avian influenza viruses in Asia

Emerging infectious diseases, 2005-10, Vol.11 (10), p.1515-1526

2005

Link zum Volltext

Verfügbarkeit prüfen

Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice

Vaccine, 2002-02, Vol.20 (11), p.1579-1585

2002

Link zum Volltext

Verfügbarkeit prüfen

Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques

Nature medicine, 2004-03, Vol.10 (3), p.290-293

2004

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004

Emerging infectious diseases, 2006-12, Vol.12 (12), p.1841-1847

2006

Link zum Volltext

Verfügbarkeit prüfen

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Journal of visualized experiments, 2019-03 (145)

2019

Link zum Volltext

Verfügbarkeit prüfen

Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

The Journal of infectious diseases, 2007-11, Vol.196 (9), p.1313-1320

2007

Link zum Volltext

Verfügbarkeit prüfen

The latest trend and prospects of development of influenza vaccine

Nihon rinshō, 2011-09, Vol.69 (9), p.1567

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(57)
Buchkapitel
(1)

Sprache

Englisch
(55)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(38)
Animals
(33)
Humans
(26)
Mice
(22)
Microbiology
(22)
Virology
(22)
Immunology
(21)
Biological And Medical Sciences
(20)
Fundamental And Applied Biological Sciences. Psychology
(19)
Infectious Diseases
(14)
Female
(13)
Influenza
(12)
Mice, Inbred Balb C
(12)
Influenza Virus
(11)
Medicine, Research & Experimental
(10)
Research & Experimental Medicine
(10)
Biochemistry & Molecular Biology
(9)
Influenza A Virus, H5n1 Subtype - Immunology
(9)
Influenza Vaccines - Administration & Dosage
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

WHO recommendations for the viruses used in the 2013–2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013

Establishment of Reference Reagents for Single-Radial-Immunodiffusion Assay on the 2022/23 Seasonal Influenza Vaccine in Japan and Their Quality Validation

Deciphering antigen-responding antibody repertoires by using next-generation sequencing and confirming them through antibody-gene synthesis

Distorted antibody repertoire developed in the absence of pre-B cell receptor formation

Efficient protection of mice from influenza A/H1N1pdm09 virus challenge infection via high avidity serum antibodies induced by booster immunizations with inactivated whole virus vaccine

Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin

Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide

Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice

Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate

Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer

Newly Established Monoclonal Antibodies for Immunological Detection of H5N1 Influenza Virus

Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection

Avirulent Avian Influenza Virus as a Vaccine Strain against a Potential Human Pandemic

Regulatory aspects of quality and safety for live recombinant viral vaccines against infectious diseases in Japan

Establishment of reference reagents for single-radial-immunodiffusion assay on the 2022/23 seasonal influenza vaccine in Japan and their quality validation

Evolution of H5N1 avian influenza viruses in Asia

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011

Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice

Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques

Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

The latest trend and prospects of development of influenza vaccine

Suchergebnisse filtern